Separation Agreements in the Pharmaceuticals Industry

375 Contracts & Agreements

Browse by Company

4Front Ventures Corp. (1 contract)
ACELRX PHARMACEUTICALS INC (2)
Aclaris Therapeutics, Inc. (2)
Acreage Holdings, Inc. (1)
Adamis Pharmaceuticals Corp (1)
ADIAL PHARMACEUTICALS, INC. (2)
Aegerion Pharmaceuticals, Inc. (1)
AEOLUS PHARMACEUTICALS, INC. (3)
AERIE PHARMACEUTICALS INC (2)
AGILE THERAPEUTICS INC (1)
Akers Biosciences, Inc. (1)
AKESIS PHARMACEUTICALS, INC. (2)
ALIMERA SCIENCES INC (1)
Allergan, plc (3)
Altus Pharmaceuticals Inc. (3)
Amag Pharmaceuticals (2)
Amneal Pharmaceuticals, Inc. (6)
Amphastar Pharma (1)
Ampio Pharmaceuticals, Inc. (1)
Amylyx Pharmaceuticals, Inc. (1)
ANADYS PHARMACEUTICALS INC (1)
Angion Biomedica Corp. (3)
ANI Pharma Inc (3)
APP Pharmaceuticals, Inc. (1)
APRICUS BIOSCIENCES, INC. (2)
Aquestive Therapeutics, Inc. (2)
Assertio Holdings, Inc. (4)
ATAI Life Sciences B.V. (2)
Athira Pharma, Inc. (3)
AUXILIUM PHARMACEUTICALS INC (8)
AVANIR PHARMACEUTICALS, INC. (2)
AYTU BIOSCIENCE, INC (1)
Baudax Bio, Inc. (1)
Bausch Health Companies Inc. (11)
BIODELIVERY SCIENCES INTERNATIONAL INC (2)
Boston Therapeutics, Inc. (1)
Canopy Growth Corp (1)
Cara Therapeutics, Inc. (1)
Cerecor Inc. (4)
CHIASMA, INC (1)
Clearside Biomedical, Inc. (2)
Clever Leaves Holdings Inc. (1)
COGNITION THERAPEUTICS INC (1)
COLLEGIUM PHARMACEUTICAL, INC (1)
Columbia Care Inc. (1)
ContraVir Pharmaceuticals, Inc. (1)
Corcept Therapeutics Incorporated (1)
CorMedix Inc. (4)
CPEX Pharmaceuticals, Inc. (1)
Cure Pharmaceutical Holding Corp. (1)
DUSA PHARMACEUTICALS INC (1)
Egalet Corp (4)
Elanco Animal Health Inc (2)
Eloxx Pharmaceuticals, Inc. (1)
ENCYSIVE PHARMACEUTICALS INC (2)
Endo International plc (4)
EPIX Pharmaceuticals, Inc. (1)
Evofem Biosciences, Inc. (4)
Evolus, Inc. (5)
Exactus, Inc. (1)
EYEGATE PHARMACEUTICALS INC (1)
EYETECH PHARMACEUTICALS INC (1)
Fresenius Kabi Pharmaceuticals Holding, Inc. (1)
Furiex Pharmaceuticals, Inc. (1)
GRAYBUG VISION, INC. (1)
GUILFORD PHARMACEUTICALS INC (1)
Harmony Biosciences Holdings, Inc. (2)
HARVEST HEALTH & RECREATION INC. (1)
Haymaker Acquisition Corp. III (1)
Horizon Pharma plc (1)
Hoth Therapeutics, Inc. (1)
iANTHUS CAPITAL HOLDINGS, INC. (3)
IMARA Inc. (4)
INNOVATE BIOPHARMACEUTICALS, INC. (6)
Innoviva, Inc. (6)
Intra-Cellular Therapies, Inc. (1)
Jazz Pharmaceuticals plc (1)
Johnson & Johnson (1)
Kaleido Biosciences, Inc. (1)
KEMPHARM, INC (1)
Landos Biopharma, Inc. (2)
Lannett Company, Inc. (6)
Level Brands, Inc. (4)
Lipocine Inc. (2)
Liquidia Corp (1)
Lyra Therapeutics, Inc. (1)
Mallinckrodt (6)
Merck (17)
Mind Medicine (MindMed) Inc. (1)
MJ Holdings, Inc. (1)
Molecular Insight Pharmaceuticals, Inc. (1)
Mylan N.V. (6)
MYnd Analytics, Inc. (3)
Nabriva Therapeutics plc (7)
NEKTAR THERAPEUTICS (9)
Neos Therapeutics, Inc. (1)
Neuralstem, Inc. (3)
NewBridge Global Ventures, Inc. (1)
Notis Global, Inc. (1)
NovaBay Pharmaceuticals, Inc. (2)
Novan, Inc. (4)
NOVEN PHARMACEUTICALS INC (1)
NPS PHARMACEUTICALS INC (2)
NUCRYST Pharmaceuticals Corp. (2)
OCULAR THERAPEUTIX, INC (7)
OncoMed Pharmaceuticals Inc (1)
Onconova Therapeutics, Inc. (1)
One World Pharma, Inc. (1)
OPIANT PHARMACEUTICALS, INC. (1)
OptiNose, Inc. (1)
Organon & Co. (2)
Paratek Pharmaceuticals, Inc. (1)
Perrigo (1)
Petros Pharmaceuticals, Inc. (1)
Pfizer (6)
Phathom Pharmaceuticals, Inc. (2)
Phibro Animal Health Corporation (1)
PLx Pharma Inc. (1)
ProPhase Labs, Inc. (1)
Pulmatrix, Inc. (2)
Recro Pharma, Inc. (2)
RELMADA THERAPEUTICS, INC. (1)
Revance Therapeutics, Inc. (5)
ROCK CREEK PHARMACEUTICALS, INC. (1)
Roivant Sciences Ltd. (1)
Sagent Pharmaceuticals, Inc. (2)
Satsuma Pharmaceuticals, Inc. (1)
SAVIENT PHARMACEUTICALS INC (2)
scPharmaceuticals Inc. (2)
SenesTech, Inc. (4)
Sienna Biopharmaceuticals, Inc. (4)
SIGA TECHNOLOGIES INC (1)
Sonoma Pharmaceuticals, Inc. (6)
Sucampo Pharmaceuticals, Inc. (4)
SYNERGY PHARMACEUTICALS, INC. (3)
Tarsus Pharmaceuticals, Inc. (1)
Terns Pharmaceuticals, Inc. (3)
Terra Tech Corp. (6)
TETRAPHASE PHARMACEUTICALS INC (1)
TEVA PHARMACEUTICAL INDUSTRIES LTD (1)
Textmunication Holdings, Inc. (2)
The Medicines Company (1)
Theravance Biopharma, Inc. (2)
Theseus Pharmaceuticals, Inc. (2)
Tilray, Inc. (4)
TILT Holdings Inc. (3)
Upjohn Inc (8)
VALEANT PHARMACEUTICALS INTERNATIONAL (1)
Vallon Pharmaceuticals, Inc. (1)
Ventyx Biosciences, Inc. (2)
VIA Pharmaceuticals, Inc. (2)
Vireo Health International, Inc. (2)
Virpax Pharmaceuticals, Inc. (2)
Vitality Biopharma, Inc. (2)
XERIS PHARMACEUTICALS INC (1)
Zoetis (3)
Zomedica Pharmaceuticals Corp. (5)
Zynerba Pharmaceuticals, Inc. (1)

Recent Contracts

Separation Agreement between Terns, Inc. and Bryan Yoon dated July 23, 2024 (Terns Pharmaceuticals, Inc., Filed With SEC on November 12, 2024)
Separation and Release Agreement, dated August 30, 2024, by and between the Registrant and Martin Auster (Ventyx Biosciences, Inc., Filed With SEC on November 7, 2024)
Separation Agreement between Adial Pharmaceuticals, Inc. and Joseph Truluck, dated November 1, 2024 (ADIAL PHARMACEUTICALS, INC., Filed With SEC on November 5, 2024)
Separation Agreement dated October 25, 2024 by and between TILT Holdings Inc. and Nathaniel Christopher Kelly (TILT Holdings Inc., Filed With SEC on October 31, 2024)
Separation Agreement between Vireo Growth Inc. and Joshua Rosen dated October 9, 2024 (Vireo Health International, Inc., Filed With SEC on October 15, 2024)
Separation Agreement and Release between Rachel Lenington and Athira Pharma, Inc. dated October 1, 2024 (Athira Pharma, Inc., Filed With SEC on October 7, 2024)
Separation Agreement and Release between Andrew Gengos and Athira Pharma, Inc. dated October 3, 2024 (Athira Pharma, Inc., Filed With SEC on October 7, 2024)
Separation Agreement, by and between the Canopy Growth Corporation and David Klein, dated August 15, 2024 (Canopy Growth Corp, Filed With SEC on August 16, 2024)
Separation Agreement, dated August 14, 2024, between Zomedica Inc. and Peter Donato (Zomedica Pharmaceuticals Corp., Filed With SEC on August 14, 2024)
Separation Agreement between Schond Greenway and Mind Medicine (MindMed) Inc., dated May 3, 2024, amended May 28, 2024 (Mind Medicine (MindMed) Inc., Filed With SEC on August 13, 2024)
Separation Agreement, by and between BioTE Medical, LLC and Mary Puncochar, dated July 3, 2024 (Haymaker Acquisition Corp. III, Filed With SEC on August 9, 2024)
Separation Agreement, by and between the Company and Joseph Ciaffoni, dated May 24, 2024 (COLLEGIUM PHARMACEUTICAL, INC, Filed With SEC on August 8, 2024)
Separation Agreement, dated as of August 2, 2024, by and between Intra-Cellular Therapies, Inc. and Lawrence J. Hineline (Intra-Cellular Therapies, Inc., Filed With SEC on August 7, 2024)
Separation Agreement, by and between the Registrant and Rabia Gurses-Ozden, dated May 29, 2024 (OCULAR THERAPEUTIX, INC, Filed With SEC on August 7, 2024)
Separation Agreement, by and between the Registrant and Antony C. Mattessich, dated May 1, 2024 (OCULAR THERAPEUTIX, INC, Filed With SEC on August 7, 2024)
Separation Agreement between Terns, Inc. and Erin Quirk dated May 7, 2024 (Terns Pharmaceuticals, Inc., Filed With SEC on August 5, 2024)
Separation Agreement and General Release, dated April 5, 2024, by and between the Company and Philippe Faraut (iANTHUS CAPITAL HOLDINGS, INC., Filed With SEC on May 14, 2024)
Separation Agreement between Virpax Pharmaceuticals, Inc. and Jeffrey Gudin, MD, dated May 2, 2024 (Virpax Pharmaceuticals, Inc., Filed With SEC on May 2, 2024)
Separation Agreement between Adial Pharmaceuticals, Inc. and Dr. Bankole Johnson, dated April 22, 2024 (ADIAL PHARMACEUTICALS, INC., Filed With SEC on April 26, 2024)
Separation Agreement and General Release by and among the Company, iAnthus Capital Management, LLC and Robert Galvin dated October 11, 2023 (iANTHUS CAPITAL HOLDINGS, INC., Filed With SEC on March 28, 2024)
Separation and Release of Claims Agreement dated March 13, 2024 between The Cannabist Company Holdings Inc. and Nicholas Vita (attached herein as Exhibit 10.24 of the Registrant's... (Columbia Care Inc., Filed With SEC on March 13, 2024)
Separation Agreement, effective December 14, 2023, between CorMedix Inc. and Phoebe Mounts (CorMedix Inc., Filed With SEC on March 12, 2024)
Separation Agreement and Release with Sanjeev Narula, dated December 15, 2023 (Upjohn Inc, Filed With SEC on February 28, 2024)
Separation Agreement and Release with Anthony Mauro, dated October 20, 2023 (Upjohn Inc, Filed With SEC on February 28, 2024)
Separation Agreement dated February 23, 2024 by and between Revance Therapeutics, Inc. and Dustin Sjuts (Revance Therapeutics, Inc., Filed With SEC on February 28, 2024)
Separation Agreement and Release, dated November 22, 2023, by and between the Registrant and William J. Sandborn (Ventyx Biosciences, Inc., Filed With SEC on February 27, 2024)
Separation Agreement, Waiver, and Release, dated as of February 4, 2024, by and between the Registrant and Douglas Manion (Aclaris Therapeutics, Inc., Filed With SEC on February 27, 2024)
Merck & Co., Inc. U.S. Separation Benefits Plan (amended and restated as of January 1, 2019) as further amended by Amendments 2019-1 (as of December 19, 2019), 2020-1 (as of... (Merck, Filed With SEC on February 26, 2024)
Form of Executive Separation Agreement (Organon & Co., Filed With SEC on February 26, 2024)
Separation Agreement between Registrant and Margaret Olinger dated December 31, 2023 (Amylyx Pharmaceuticals, Inc., Filed With SEC on February 22, 2024)
Separation Agreement between Mr. Stephen Bardin and atai Life Sciences N.V., dated February 6, 2024 (ATAI Life Sciences B.V., Filed With SEC on February 6, 2024)
Separation Agreement and General Release, dated January 2, 2024, by and between Alimera Sciences, Inc. and Russell Skibsted (ALIMERA SCIENCES INC, Filed With SEC on January 4, 2024)
Separation and Release Agreement, by and between Theseus Pharmaceuticals, Inc. and David Kerstein, M.D., effective as of December 7, 2023 (Theseus Pharmaceuticals, Inc., Filed With SEC on December 4, 2023)
Separation and Release Agreement, by and between Theseus Pharmaceuticals, Inc. and Timothy P. Clackson, Ph.D., effective as of December 7, 2023 (Theseus Pharmaceuticals, Inc., Filed With SEC on December 4, 2023)
Separation Agreement between Terns, Inc. and Senthil Sundaram dated August 2, 2023 (Terns Pharmaceuticals, Inc., Filed With SEC on November 14, 2023)
Separation Agreement dated September 21, 2023, between Vireo Health, Inc., and John Heller (Vireo Health International, Inc., Filed With SEC on November 14, 2023)
Employment Mutual Separation Agreement, dated November 13, 2023, by and between MyMD Pharmaceuticals, Inc. and Paul M. Rivard (Akers Biosciences, Inc., Filed With SEC on November 14, 2023)
Transition and Separation Agreement, dated August 17, 2023, by and between Agile Therapeutics, Inc. and Jason Butch (AGILE THERAPEUTICS INC, Filed With SEC on November 9, 2023)
Separation Agreement, dated May 4, 2023, by and between Registrant and Leonard Greenstein (Tarsus Pharmaceuticals, Inc., Filed With SEC on August 10, 2023)
Employment Separation and Release Agreement effective as of June 19, 2023 by and between Nektar Therapeutics and Jillian B. Thomsen (NEKTAR THERAPEUTICS, Filed With SEC on August 9, 2023)